Group 1 - The core point of the article is that Jinxin Reproductive Medicine (01951) has proposed a 2025 Share Option Plan, which aims to align the long-term interests of the company's directors and key employees with those of the company, thereby incentivizing them to drive growth and development [1] - The 2025 Share Option Plan will constitute a share option scheme funded through the issuance of new shares, in accordance with Chapter 17 of the Listing Rules [1] - On September 25, 2025, the board resolved to grant a total of 137,235,000 share options to the management under the 2025 Share Option Plan, subject to conditional approval from independent shareholders at a special general meeting [1] Group 2 - Additionally, the board plans to grant a total of 2,400,000 share options and 1,200,000 restricted shares to non-executive participants under the 2025 Share Option Plan [1]
锦欣生殖建议采纳2025年股份计划